These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12775494)

  • 21. Large-scale databases in toxicogenomics.
    Salter AH
    Pharmacogenomics; 2005 Oct; 6(7):749-54. PubMed ID: 16207151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
    Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
    Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of genomics, proteomics and metabolomics in drug discovery, development and clinic.
    Russell C; Rahman A; Mohammed AR
    Ther Deliv; 2013 Mar; 4(3):395-413. PubMed ID: 23442083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database.
    Ganter B; Snyder RD; Halbert DN; Lee MD
    Pharmacogenomics; 2006 Oct; 7(7):1025-44. PubMed ID: 17054413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The state-of-the-art in predictive toxicogenomics.
    Fielden MR; Kolaja KL
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):84-91. PubMed ID: 16445120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environmental toxicogenomics: a post-genomic approach to analysing biological responses to environmental toxins.
    Jayapal M; Bhattacharjee RN; Melendez AJ; Hande MP
    Int J Biochem Cell Biol; 2010 Feb; 42(2):230-40. PubMed ID: 19836462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A computational toxicogenomics approach identifies a list of highly hepatotoxic compounds from a large microarray database.
    Rueda-Zárate HA; Imaz-Rosshandler I; Cárdenas-Ovando RA; Castillo-Fernández JE; Noguez-Monroy J; Rangel-Escareño C
    PLoS One; 2017; 12(4):e0176284. PubMed ID: 28448553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in applying genomics in drug development.
    Lord PG
    Toxicol Lett; 2004 Apr; 149(1-3):371-5. PubMed ID: 15093283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of applying toxicogenomics to increase the efficiency of drug discovery.
    Barros SA
    Pharmacogenomics; 2005 Sep; 6(6):547-50. PubMed ID: 16142994
    [No Abstract]   [Full Text] [Related]  

  • 30. Toxicogenomics strategies for predicting drug toxicity.
    Martin R; Rose D; Yu K; Barros S
    Pharmacogenomics; 2006 Oct; 7(7):1003-16. PubMed ID: 17054411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats.
    Hanafusa H; Morikawa Y; Uehara T; Kaneto M; Ono A; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2014 Oct; 324():43-54. PubMed ID: 25051504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Toxicogenomics as a tool for evaluation of chemical effects].
    Watanabe H
    Yakugaku Zasshi; 2007 Dec; 127(12):1967-74. PubMed ID: 18057786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel technologies for the discovery and quantitation of biomarkers of toxicity.
    Collings FB; Vaidya VS
    Toxicology; 2008 Mar; 245(3):167-74. PubMed ID: 18237837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systems biology and functional genomics approaches for the identification of cellular responses to drug toxicity.
    Harrill AH; Rusyn I
    Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1379-89. PubMed ID: 18950280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
    Lühe A; Suter L; Ruepp S; Singer T; Weiser T; Albertini S
    Mutat Res; 2005 Aug; 575(1-2):102-15. PubMed ID: 15924886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers for drug-induced liver injury.
    Shi Q; Hong H; Senior J; Tong W
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):225-34. PubMed ID: 20350268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood transcriptomics: applications in toxicology.
    Joseph P; Umbright C; Sellamuthu R
    J Appl Toxicol; 2013 Nov; 33(11):1193-202. PubMed ID: 23456664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward a public toxicogenomics capability for supporting predictive toxicology: survey of current resources and chemical indexing of experiments in GEO and ArrayExpress.
    Williams-Devane CR; Wolf MA; Richard AM
    Toxicol Sci; 2009 Jun; 109(2):358-71. PubMed ID: 19332651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The development of computational toxicology and application in risk assessment of chemicals].
    Zhang R; Chen W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Aug; 53(8):843-850. PubMed ID: 31378047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of toxicogenomics in hepatic systems toxicology for risk assessment: acetaminophen as a case study.
    Kienhuis AS; Bessems JG; Pennings JL; Driessen M; Luijten M; van Delft JH; Peijnenburg AA; van der Ven LT
    Toxicol Appl Pharmacol; 2011 Jan; 250(2):96-107. PubMed ID: 20970440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.